Aditxt Inc. share price logo

Aditxt Inc.

NASDAQ: ADTX

Small Cap

$0.14

-0.06

(-28.91%)

as on

Aditxt Inc. Stock Performance

as on May 5, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.12
    $0.16
    downward going graph

    14.29%

    Downside

    14.29%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.12
    $2,495.04
    downward going graph

    16.43%

    Downside

    1782071.43%

    Upside

    downward going graph

Aditxt Inc. share price movements today

Previous Close
$0.20
Open
$0.16
Volume
4.2M
Day's Low - High
$0.12 - $0.16
52 Week Low - High
$0.12 - $2,495.04

Aditxt Inc. Historical Returns

1 Month Return
-82.38 %
3 Month Return
-97.19 %
1 Year Return
-99.99 %
3 Year Return
-100 %
5 Year Return
-100 %

Aditxt Inc. Stock Fundamentals & Key Indicators

Check Aditxt Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$176.5K

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-19.3M

Revenue (TTM)

3.2K

Profit Margin

0.00%

Return On Equity TTM

-699.13%

Aditxt Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aditxt Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Aditxt Inc. image
Aditxt Inc.
SELL$176.5K-100%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.8B124.56%74.6712.55%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$109.3B100.99%27.732.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$33.0BNA118.865.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$73.5B47.01%17.1229.65%

Stock Returns calculator for Aditxt Inc. Stock including INR - Dollar returns

The Aditxt Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Aditxt Inc. investment value today

Current value as on today

₹8

Returns

-₹99,992

(-99.99%)

Returns from Aditxt Inc. Stock

-₹99,993 (-99.99%)

Dollar Impact

₹1 (+0.00%)

Analyst Recommendation on Aditxt Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Aditxt Inc.. Average target price of $61

Aditxt Inc. Share Price Target

Get share price movements and forecasts by analysts on Aditxt Inc..

What analysts predicted

99.77%UPSIDE

Target Price

$61

Current Price

$0.14

Analyzed by

6 Analysts

Target

$61.00

Aditxt Inc. target price $61, a slight upside of 99.77% compared to current price of $0.14. According to 6 analysts rating.

Aditxt Inc. Stock’s Investor Sentiment and Interest

Search interest for Aditxt Inc. Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-10% versus previous 30 day period

Aditxt Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-8
-7
-11
-5
-4
-5
-5
-6
-3
-4
EBITDA
-7
-
-11
-5
-4
-5
-5
-6
-23
-4
Interest Expense
1
3
3
1
2
0
0
1
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-9
-10
-14
-7
-6
-5
-5
-7
-24
-5
Income Tax Expense
0
-
0
0
5
5,333
0
-
-
314
Net Income
-9
-10
-14
-7
-6
-5
-5
-7
-24
-4
Net Profit Margin
-7828.91%
-13491.53%
-18486.10%
-17051.27%
-101262.21%
-164618.20%
-560934.09%
-722789.64%
-3214626.34%
-1106277.41%

Aditxt Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
0
0
0
0
0
Gross Profit
-
-
0
0
0
0
0
0
Operating Income
-5
-5
-8
-41
-25
-26
-27
-19
EBITDA
-5
-5
-8
-43
-24
-25
-27
-40
Interest Expense
0
0
0
1
2
6
7
2
Depreciation
-
-
0
0
0
0
0
0
Income Before Tax
-5
-5
-9
-46
-27
-32
-35
-42
Income Tax Expense
0
0
0
1
0
0
5,333
314
Net Income
-5
-5
-9
-46
-27
-32
-34
-41
Net Profit Margin
0.00%
0.00%
0.00%
-44148.56%
-2961.29%
-5018.92%
-25708.85%
-1305608.79%

Aditxt Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-10
-14
-7
-6
-5
-5
-7
-24
-42,749
Operating Cash Flow
-3
-5
-2
-2
-6
-11
-2
-2
-9
Investing Cash Flow
-
-
-1
-1
-2
-
-2
2
0
Financing Cash Flow
1
5
3
3
9
11
4
2
12
Change in Cash
-1
0
0
0
0
0
0
0
3

Aditxt Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-5
-5
-9
-46
-27
-32
-34
-42,787
Operating Cash Flow
0
0
-7
-22
-22
-18
-16
-25,688
Investing Cash Flow
0
0
0
-16
0
0
-5
-2,438
Financing Cash Flow
0
0
17
35
17
16
22
30,492
Change in Cash
0
0
10
-2
-5
-2
0
2,365

Global Institutional Holdings in Aditxt Inc.

Funds
Holdings
JONES FINANCIAL COMPANIES LLLP
0%
IFP Advisors, LLC
0%
Susquehanna International Group, LLP
0.22%
Advisor Group Holdings, Inc.
0%
Virtu Financial LLC
0%
See all

Insights on Aditxt Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -24.04M → -4.70M (in $), with an average increase of 411.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Aditxt Inc has experienced a drawdown of -100.0%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 93.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 17.5% return, outperforming this stock by 117.5%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 11 quarters, 220.97K → 425.0 (in $), with an average decrease of 40.1% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ADTX stock has moved down by -35.9%

About Aditxt Inc.

Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women's health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.
OrganisationAditxt Inc.
Headquarters2569 Wyandotte Street, Mountain View, CA, United States, 94043
IndustryBiotechnology
CEOMr. Amro A. Albanna
E-voting on sharesClick here to vote

Key Management of Aditxt Inc.

Name

Title

Mr. Christopher J. Porcelli

General Counsel & Chief People Officer

Dr. Dolly B. Tyan D(ABHI), Ph.D.

Senior Vice President of Clinical Development ? Transplantation

Mr. Ge Chen M.D., M.S.

Senior Vice President of Preclinical Research & Discovery

Ms. Jennifer Lee

Director of Human Resources

Mr. Amro A. Albanna

Co-Founder, Chairman & CEO

Ms. Corinne D. Pankovcin CPA, M.B.A.

Chief Mergers & Acquisitions Officer

Ms. Rowena Albanna

Chief Operating Officer

Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D.

Co-Founder, Chief Innovation Officer, Secretary & Director

Mr. Thomas J. Farley CPA

Chief Financial Officer

FAQs

What is Aditxt Inc. share price today?

Aditxt Inc. share price today is $0.14 as on at the close of the market. Aditxt Inc. share today touched a day high of $0.16 and a low of $0.12.

What is the 52 week high and 52 week low for Aditxt Inc. share?

Aditxt Inc. share touched a 52 week high of $2,495.04 on and a 52 week low of $0.12 on . Aditxt Inc. stock price today i.e. is closed at $0.14,which is 99.99% down from its 52 week high and 19.66% up from its 52 week low.

What is Aditxt Inc.'s market capitalisation today?

Aditxt Inc. market capitalisation is $0.00T as on .

How to invest in Aditxt Inc. Stock (ADTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aditxt Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aditxt Inc. Shares that will get you 10.7143 shares as per Aditxt Inc. share price of $0.14 per share as on May 5, 2026 at 1:29 am IST.

What is the minimum amount required to buy Aditxt Inc. Stock (ADTX) from India?

Indian investors can start investing in Aditxt Inc. (ADTX) shares with as little as ₹95.28 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in Aditxt Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Aditxt Inc. share’s latest price of $0.14 as on May 5, 2026 at 1:29 am IST, you will get 71.4286 shares of Aditxt Inc.. Learn more about fractional shares .

What are the returns that Aditxt Inc. has given to Indian investors in the last 5 years?

Aditxt Inc. stock has given -100% share price returns and 28.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?